{"organizations": [], "uuid": "de49e0ecfd3ab081b0394b313867826ff8279aff", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-sinovac-biotech-issues-statement-i/brief-sinovac-biotech-issues-statement-in-response-to-statements-by-shandong-sinobioway-biomedicine-co-ltd-idUSFWN1RV0WP", "country": "US", "domain_rank": 408, "title": "BRIEF-Sinovac Biotech Issues Statement In Response To Statements By Shandong Sinobioway Biomedicine Co Ltd", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-18T23:36:00.000+03:00", "replies_count": 0, "uuid": "de49e0ecfd3ab081b0394b313867826ff8279aff"}, "author": "", "url": "https://www.reuters.com/article/brief-sinovac-biotech-issues-statement-i/brief-sinovac-biotech-issues-statement-in-response-to-statements-by-shandong-sinobioway-biomedicine-co-ltd-idUSFWN1RV0WP", "ord_in_thread": 0, "title": "BRIEF-Sinovac Biotech Issues Statement In Response To Statements By Shandong Sinobioway Biomedicine Co Ltd", "locations": [], "entities": {"persons": [], "locations": [{"name": "shandong", "sentiment": "none"}, {"name": "beijing", "sentiment": "none"}], "organizations": [{"name": "shandong sinobioway biomedicine co ltd", "sentiment": "negative"}, {"name": "sinobioway biomedicine co ltd", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "shandong sinobioway biomedicine co ltd reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 18, 2018 / 8:37 PM / Updated 15 minutes ago BRIEF-Sinovac Biotech Issues Statement In Response To Statements By Shandong Sinobioway Biomedicine Co Ltd Reuters Staff \nApril 18 (Reuters) - Shandong Sinobioway Biomedicine Co Ltd : \n* SINOVAC BIOTECH LTD - ISSUES STATEMENT IN RESPONSE TO STATEMENTS BY SHANDONG SINOBIOWAY BIOMEDICINE CO LTD \n* SINOVAC BIOTECH LTD - SINOVAC BEIJING HAS NOT REFUSED TO PROVIDE FINANCIAL STATEMENTS REQUESTED BY SINOBIOWAY BIOMEDICINE CO LTD \n* SINOVAC BIOTECH LTD SAYS HAVE BEEN IN REGULAR COMMUNICATIONS WITH SINOBIOWAY REGARDING PLANNED TIMING OF COMPLETION OF ANNUAL AUDIT Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-18T23:36:00.000+03:00", "crawled": "2018-04-18T23:55:30.009+03:00", "highlightTitle": ""}